180 related articles for article (PubMed ID: 26013205)
1. The Correlation Between RhoA Expression and Clinicopathological Characteristics in Gastric Cancer Patients After Curative Surgery.
Huang KH; Lan YT; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Chiou SH; Yang MH; Shyr YM; Fang WL
World J Surg; 2015 Sep; 39(9):2289-99. PubMed ID: 26013205
[TBL] [Abstract][Full Text] [Related]
2. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
4. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.
Baiocchi GL; Molfino S; Baronchelli C; Giacopuzzi S; Marrelli D; Morgagni P; Bencivenga M; Saragoni L; Vindigni C; Portolani N; Botticini M; De Manzoni G
World J Gastroenterol; 2017 Dec; 23(45):8000-8007. PubMed ID: 29259375
[TBL] [Abstract][Full Text] [Related]
5. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
6. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
[No Abstract] [Full Text] [Related]
7. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
9. Caspase-3, a key apoptotic protein, as a prognostic marker in gastric cancer after curative surgery.
Huang KH; Fang WL; Li AF; Liang PH; Wu CW; Shyr YM; Yang MH
Int J Surg; 2018 Apr; 52():258-263. PubMed ID: 29501797
[TBL] [Abstract][Full Text] [Related]
10. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
[TBL] [Abstract][Full Text] [Related]
11. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
13. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
15. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
18. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on surgical method and prognosis in diffuse-type advanced gastric cancer].
Yang J; Li L; Zhang G; Zhou H; Yu Z; Jiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):151-7. PubMed ID: 26932212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
